A. Idbaih

Discipline

Psychologie (3)

Type de document

Articles (6) Recensions (1)

Co-auteur

Date

Source

Mot-clé

Patients (6) Patients (6) thérapie (5) Treatment (5) Therapeutics (5) analyse (4) maladie (4) procès (4) Months (4) Human beings (4) Analysis (4) maladie (4) temps (durée) (3) sécurité (3) oncologie (3) âge (3) cancer (3) survie (3) Diagnosis (3) Chemotherapy (3) Cancer (3) Ci (Chinese poetry) (3) Time (3) Survival (3) Scalp (3) Oncology (3) Maintenance (3) Diagnosis (3) Chemotherapy (3) Cancer (3)

Documents écrit par A. Idbaih (6) | parle de A. Idbaih (0)

Corrigendum: Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients With Newly Diagnosed Glioblastoma: Subgroup Analysis of methe Phase 3 EF-14 Clinical Trial.
Z. Ram et al. (2022)
Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients with Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial.
Z. Ram et al. (2021)
Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19).
A. Lièvre et al.
A review of the international early recommendations for departments organization and cancer management priorities during the global COVID-19 pandemic: applicability in low- and middle-income countries.
Y. Belkacemi et al.
Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial.
R. Stupp et al. (19 déc. 2017)
Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial.
R. Stupp et al. (2015)